about
Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancerMicroRNAs in colorectal cancer: role in metastasis and clinical perspectivesRoles of long noncoding RNAs in colorectal cancer metastasis.Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2.Metastatic colorectal cancer: systemic treatment in the new millennium.Prognostic factors and multidisciplinary treatment modalities for brain metastases from colorectal cancer: analysis of 93 patients.A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancerCetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial.A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma.Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.Up-regulation of Na(+),K(+)-ATPase alpha 3-isoform and down-regulation of the alpha1-isoform in human colorectal cancer.The efficacy and safety of hepatic arterial infusion of oxaliplatin plus intravenous irinotecan, leucovorin and fluorouracil in colorectal cancer with inoperable hepatic metastasis.Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan.Exploration of the mechanism of colorectal cancer metastasis using microarray analysis.
P2860
Q24795784-C8FD994A-C875-4790-A8AB-4692BCA84E6DQ27022292-C8E7EEB9-5FCC-4A82-8613-D0F68D8BB860Q33889417-1E1AA121-B93E-45CB-94C4-2FB718C2A4F0Q34652269-86F802FC-3C67-4083-BA17-2D9E16DC1FEAQ35148795-9B72B94E-2D98-4EB2-AFA6-E0B6D3615409Q35842542-14EDE067-D21C-4162-A83A-0497DDDD5129Q36610441-AC409A3A-7B94-46B1-B6C7-6340B2D1FC67Q36614517-7A33C96A-7C4F-40FF-B5EA-3410803B78AAQ36695083-70E1833A-DD1E-4C66-B7D9-BACF41FD1D3FQ37540024-7A80A6EE-6336-4EDC-B6D4-6500C5716EC6Q40570320-90D27917-A78F-441D-9468-C45B82F18E87Q41713124-1ADB7671-B38D-4EDB-A3E7-DB4638D1B1E5Q42510237-35892AC5-8D8F-4C50-890B-2A1F6855C849Q44275430-2044A7A1-0EB0-438A-A18C-FF4E501B5FDA
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
New chemotherapy approaches in colorectal cancer.
@ast
New chemotherapy approaches in colorectal cancer.
@en
New chemotherapy approaches in colorectal cancer.
@nl
type
label
New chemotherapy approaches in colorectal cancer.
@ast
New chemotherapy approaches in colorectal cancer.
@en
New chemotherapy approaches in colorectal cancer.
@nl
prefLabel
New chemotherapy approaches in colorectal cancer.
@ast
New chemotherapy approaches in colorectal cancer.
@en
New chemotherapy approaches in colorectal cancer.
@nl
P1476
New chemotherapy approaches in colorectal cancer.
@en
P2093
P304
P356
10.1097/00001622-200107000-00011
P577
2001-07-01T00:00:00Z